Publication: 2676

Publication: 2676

Genetic correlates of therapeutic toxicities of stage III colon cancer (CC) patients treated with adjuvant FOLFOX+/-cetuximab (Alliance NCCTG N0147)

URL

Google Scholar

Citation:: J Clin Oncol vol 35 (15 suppl) abstr 3604

Meeting Instance:: ASCO 2017
Year:: 2017
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 3234

Program:: TRP
Primary Committee:: PPP
Sec. Committees:: GI

Pharmas:: Sanofi, Eli Lilly
Grants:: U10CA180821, U10CA180882, U10CA180820, U10CA180863, U10CA180888, CCSRI 021039

Corr. Author:
Authors:: Polly A. Newcomb Wei Sun Xinwei Hua Barbara Banbury Amanda I. Phipps Jonathan M. Kocarnik Tabitha A. Harrison Qian Shi Frank Sinicrope Steve Thibodeau Emily Chan Sharlene Gill Richard M. Goldberg Morton Kahlenberg Suresh Nair Anthony Shields Ulrike Peters Steve R. Alberts Andrew T. Chan

Networks:: LAPS-MN026, LAPS-OH007, MCRC

Study: NCCTG-N0147
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: